Evidence-based treatment for depressive disorder.
作者信息
Pae Chi-Un
机构信息
Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea. ; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.
出版信息
Psychiatry Investig. 2015 Apr;12(2):278-9. doi: 10.4306/pi.2015.12.2.278. Epub 2015 Mar 18.
Abstract
摘要
相似文献
1
Evidence-based treatment for depressive disorder.抑郁症的循证治疗
Psychiatry Investig. 2015 Apr;12(2):278-9. doi: 10.4306/pi.2015.12.2.278. Epub 2015 Mar 18.
2
The Korean Medication Algorithm for Major Depressive Disorder (KMA-MDD): Report of the Korean Society of Depressive and Bipolar Disorders.《韩国重性抑郁障碍药物治疗算法（KMA-MDD）》：韩国抑郁及双相障碍学会报告。
Int J Psychiatry Clin Pract. 2006;10(3):186-94. doi: 10.1080/13651500600633584.
3
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions.世界生物精神病学协会联盟（WFSBP）单相抑郁障碍生物治疗指南，第2部分：重度抑郁症的维持治疗以及慢性抑郁症和阈下抑郁症的治疗。
World J Biol Psychiatry. 2002 Apr;3(2):69-86. doi: 10.3109/15622970209150605.
4
[Integral Care Guide for Early Detection and Diagnosis of Depressive Episodes and Recurrent Depressive Disorder in Adults. Integral Attention of Adults with a Diagnosis of Depressive Episodes and Recurrent Depressive Disorder: Part III: Treatment of Resistant Depression and Psychotic Depression, Occupational Therapy and Day Hospital Treatment].
Rev Colomb Psiquiatr. 2012 Dec;41(4):774-86. doi: 10.1016/S0034-7450(14)60046-9. Epub 2014 May 10.
5
Sexual minority youth and depressive symptoms or depressive disorder: A systematic review and meta-analysis of population-based studies.性少数青年与抑郁症状或抑郁症：基于人群研究的系统评价与荟萃分析
Aust N Z J Psychiatry. 2017 Aug;51(8):774-787. doi: 10.1177/0004867417713664. Epub 2017 Jun 1.
6
Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder.有证据表明，患有重度抑郁症的儿童和青少年大脑皮质谷氨酸能传递增强。
JAMA Psychiatry. 2013 Mar;70(3):291-9. doi: 10.1001/2013.jamapsychiatry.24.
8
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.21 种抗抑郁药治疗成人重度抑郁症的急性治疗的疗效和可接受性比较：系统评价和网络荟萃分析。
Lancet. 2018 Apr 7;391(10128):1357-1366. doi: 10.1016/S0140-6736(17)32802-7. Epub 2018 Feb 21.
9
The potential of transcranial photobiomodulation therapy for treatment of major depressive disorder.经颅光生物调节疗法治疗重度抑郁症的潜力。
Rev Neurosci. 2017 May 24;28(4):441-453. doi: 10.1515/revneuro-2016-0087.
10
Tobacco smoking as a risk factor for major depressive disorder: population-based study.吸烟作为重度抑郁症的一个风险因素：基于人群的研究。
Br J Psychiatry. 2008 Oct;193(4):322-6. doi: 10.1192/bjp.bp.107.046706.
引用本文的文献
1
The Association between Post-Stroke Depression and the Activities of Daily Living/Gait Balance in Patients with First-Onset Stroke Patients.首发脑卒中患者卒中后抑郁与日常生活活动/步态平衡的相关性
Psychiatry Investig. 2016 Nov;13(6):659-664. doi: 10.4306/pi.2016.13.6.659. Epub 2016 Nov 24.
2
Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice.优化阿立哌唑增效治疗重度抑郁症的应用：从临床试验到临床实践
Chonnam Med J. 2015 Aug;51(2):66-80. doi: 10.4068/cmj.2015.51.2.66. Epub 2015 Aug 17.
本文引用的文献
1
Revised psychopharmacological algorithms for the treatment of mood disorders in Japan.日本心境障碍治疗的修订精神药理学算法。
Int J Psychiatry Clin Pract. 2008;12(1):11-8. doi: 10.1080/13651500701330791.
2
Korean medication algorithm for depressive disorder: comparisons with other treatment guidelines.韩国抑郁症药物治疗算法：与其他治疗指南的比较
Psychiatry Investig. 2014 Jan;11(1):1-11. doi: 10.4306/pi.2014.11.1.1. Epub 2014 Jan 21.
3
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.世界生物精神病学学会联合会（WFSBP）单相抑郁障碍的生物学治疗指南，第 1 部分：单相抑郁障碍的急性和维持治疗更新 2013 年版。
World J Biol Psychiatry. 2013 Jul;14(5):334-85. doi: 10.3109/15622975.2013.804195. Epub 2013 Jul 3.
4
Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder.基于指南的重度抑郁症治疗中，非典型抗精神病药物的增效策略。
CNS Drugs. 2013 May;27 Suppl 1:S29-37. doi: 10.1007/s40263-012-0031-0.
5
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.联合用药增强抑郁治疗效果（CO-MED）：一项单盲随机研究的急性期和长期结局。
Am J Psychiatry. 2011 Jul;168(7):689-701. doi: 10.1176/appi.ajp.2011.10111645. Epub 2011 May 2.
6
Unipolar depression: diagnostic and therapeutic recommendations from the current S3/National Clinical Practice Guideline.单相抑郁障碍：当前 S3 指南/国家临床实践指南的诊断和治疗建议。
Dtsch Arztebl Int. 2010 Oct;107(40):700-8. doi: 10.3238/arztebl.2010.0700. Epub 2010 Oct 8.
7
Major depressive disorder treatment guidelines in China.中国重度抑郁症治疗指南。
J Clin Psychiatry. 2010;71 Suppl E1:e06. doi: 10.4088/JCP.9058se1c.06gry.
8
Major depressive disorder treatment guidelines in Japan.日本重度抑郁症治疗指南。
J Clin Psychiatry. 2010;71 Suppl E1:e05. doi: 10.4088/JCP.9058se1c.05gry.
9
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.加拿大情绪与焦虑治疗网络（CANMAT）成人重度抑郁症管理临床指南。三、药物治疗。
J Affect Disord. 2009 Oct;117 Suppl 1:S26-43. doi: 10.1016/j.jad.2009.06.041. Epub 2009 Aug 11.
10
AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program.AHRQ 系列论文 5：比较医疗干预措施时证据体的力度分级——医疗保健研究和质量机构和有效医疗保健计划。
J Clin Epidemiol. 2010 May;63(5):513-23. doi: 10.1016/j.jclinepi.2009.03.009.
Zotero 插件